The Frist Art Museum has announced that five board members have been elected to the Frist Art Museum Board of Trustees. Learn ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, gene ...